Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

AGM Trading Update

26 Jan 2024 07:00

RNS Number : 9819A
Avon Protection PLC
26 January 2024
 

 26 January 2024

Avon Protection plc

("Avon" or "the Group")

AGM Trading Update - Continued strategic and operational progress

 

Avon Protection plc is pleased to announce a trading update for the first quarter of its 2024 financial year ("Q1"), ahead of its Annual General Meeting today.

 

Trading update

Order intake for the first quarter was 36% higher than the prior year, reflecting strong demand for helmets and rebreathers, following the recently announced contract from the German Navy, partially offset by a modest decline in respirator orders. The order book was 21% higher than the prior year. Year-on-year revenue growth of 27% was in line with our expectations, reflecting the continued successful delivery of NG IHPS helmets to the U.S. DOD and robust demand for pads and commercial helmets. 

 

As expected, cash conversion was very strong reflecting the unwind of the elevated FY23 year-end receivables balance following the high volume of deliveries in the final quarter of FY23.

 

Following the successful First Article Testing process on the ACH GEN II helmet, work is now ongoing to ramp up production ahead of product deliveries in the second half.

Continued strategic progress

Our focus on operational excellence and continuous improvement is now starting to deliver the expected scrap reduction benefits and recent actions taken in support of functional excellence will start to deliver benefits in H2 2024, in line with expectations.

Our transformation programme is progressing in line with our plan. In December 2023 we informed employees about our plan to close our Irvine, California facility by Summer 2025 as part of our site optimisation programme. Benefits from the consolidation of the California production into our other Head Protection sites will begin in FY26 and will significantly improve competitiveness and financial performance over the medium term. 

FY24 outlook unchanged

The trading performance in the first quarter, and the progress made to date on transformation, support our full year expectations of high single-digit revenue growth and solid progression in adjusted operating margin in H2.

 

Capital markets day

Our capital markets day will highlight Avon's deep technical expertise, supportive addressable markets and strong position to grow above those markets. The Group will also present additional details around its transformation programme, including the roadmap to deliver Avon's margin and return on capital targets.

 

For further details, and to register to attend the event, please contact avonprotection@mhpgroup.com.

 

Jos Sclater, Chief Executive Officer, said:

 

"After a year of strengthening the business, we are now focused on our objectives of creating a competitive advantage through superior execution, growing faster than our markets by delivering new and improved products to our customers, and increasing margins through our transformation programme. While there remain a number of opportunities and risks for us to navigate in the year ahead, I am pleased to see the results start to reflect the strategic and operational progress we are making. We remain focused on the actions required to deliver our medium-term objectives."

 

Avon will report its half year results for the six months ending 31 March 2024 on 21 May 2024. Prior to this, the Group will host a capital markets day on 8 February 2024.

 

For further enquiries, please contact:

 

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

 

MHP

Tim Rowntree

+44 7817 458804

Ollie Hoare

avonprotection@mhpgroup.com

 

Legal Entity Identifier: 213800JM1AN62REBWA71

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

About Avon Protection plc:

Avon Protection plc make products that are trusted to protect the world's militaries and first responders through its two brands Avon Protection and Team Wendy.

Our dedicated teams achieve this by developing mission-critical solutions that enhance our customers' performance, efficiency and capability, whilst providing ever-increasing levels of protection.

With a portfolio that includes respiratory and head protection systems, we are renowned for our innovative thinking and our steadfast approach to manufacturing unrivalled products.

For further information, please visit our website www.avon-protection-plc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZMGKLGDZZ
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.